Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (41-50 of 455) with videos related to

Pageof 46
Sort By:
Histochemistry and Cell Biology|December 20, 2022
Lower HLA-G levels in extravillous trophoblasts of human term placenta in gestational diabetes mellitus than in normal controlsJulia Knabl, Rebecca Hüttenbrenner, Sven Mahner, et al.
MMW Fortschritte Der Medizin|January 26, 2023
Susanne Beyer, Fabian Trillsch, Bernd Kost, et al.
Oncology Reports|June 11, 2009
Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell linesSibyll Hein, Sven Mahner, Christine Kanowski, et al.
Histochemistry and Cell Biology|November 15, 2017
Prostaglandin E2 receptor EP1 in healthy and diseased human endometriumJunyan Zhu, Doris Mayr, Christina Kuhn, et al.
Expert Review of Anticancer Therapy|July 11, 2009
Role of cytoreductive surgery in recurrent ovarian cancerPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Journal of Cancer Research and Clinical Oncology|August 15, 2013
The prognostic significance of Jun transcription factors in ovarian cancerKerstin Eckhoff, Roland Flurschütz, Fabian Trillsch, et al.
Expert Review of Anticancer Therapy|December 18, 2009
Systemic therapy in recurrent ovarian cancer: current treatment options and new drugsPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Integrating antibody drug conjugates in the management of gynecologic cancersAnca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore, et al.
MMW Fortschritte Der Medizin|August 16, 2019
[Breast cancer in young women]D-Maximiliane Burgmann, Franziska Dobler, Christine Zeder-Göss, et al.
International Journal of Molecular Sciences|December 19, 2018
Histone H3 lysine 9 acetylation is downregulated in GDM Placentas and Calcitriol supplementation enhanced this effectPaula Hepp, Stefan Hutter, Julia Knabl, et al.
Pageof 46

Showing results (41-50 of 455) with videos related to

Sort By:
Pageof 46
Histochemistry and Cell Biology|December 20, 2022
Lower HLA-G levels in extravillous trophoblasts of human term placenta in gestational diabetes mellitus than in normal controlsJulia Knabl, Rebecca Hüttenbrenner, Sven Mahner, et al.
MMW Fortschritte Der Medizin|January 26, 2023
Susanne Beyer, Fabian Trillsch, Bernd Kost, et al.
Oncology Reports|June 11, 2009
Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell linesSibyll Hein, Sven Mahner, Christine Kanowski, et al.
Histochemistry and Cell Biology|November 15, 2017
Prostaglandin E2 receptor EP1 in healthy and diseased human endometriumJunyan Zhu, Doris Mayr, Christina Kuhn, et al.
Expert Review of Anticancer Therapy|July 11, 2009
Role of cytoreductive surgery in recurrent ovarian cancerPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Journal of Cancer Research and Clinical Oncology|August 15, 2013
The prognostic significance of Jun transcription factors in ovarian cancerKerstin Eckhoff, Roland Flurschütz, Fabian Trillsch, et al.
Expert Review of Anticancer Therapy|December 18, 2009
Systemic therapy in recurrent ovarian cancer: current treatment options and new drugsPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Integrating antibody drug conjugates in the management of gynecologic cancersAnca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore, et al.
MMW Fortschritte Der Medizin|August 16, 2019
[Breast cancer in young women]D-Maximiliane Burgmann, Franziska Dobler, Christine Zeder-Göss, et al.
International Journal of Molecular Sciences|December 19, 2018
Histone H3 lysine 9 acetylation is downregulated in GDM Placentas and Calcitriol supplementation enhanced this effectPaula Hepp, Stefan Hutter, Julia Knabl, et al.
Pageof 46